Alireza Daneshvar is a visionary biopharmaceutical scientist, entrepreneur, and Forbes 30 Under 30 honoree, leading innovations in cell and gene therapy. As the Founder and CEO of Pioneera Biosciences, he is at the forefront of developing cutting-edge therapeutics, specializing in CAR-T, CAR-NK, and adoptive T-cell therapies for cancer and infectious diseases.

With a background in Doctor of Pharmacy - Master of Public Health, Alireza’s research focuses on novel fusion protein delivery via mRNA-LNP and liposomal systems, enhancing the efficacy and durability of immune cell therapies. His expertise spans vector manufacturing, cell processing, and clinical trial design, where he has successfully spearheaded multiple Phase 1 and Phase 2b trials for advanced cell-based immunotherapies.

Alireza is also deeply engaged in biotech ecosystem development, and volunteering at Notable Organizations including Nucleate, he is driving initiatives to establish a global research ecosystm in advanced therapeutics. 

An award-winning Chemistry Olympiad Gold Medalist and ex-Founder in Residence at Entrepreneur First, Alireza combines scientific excellence with entrepreneurial acumen. He is an active speaker at global biotech summits and has secured funding and partnerships to scale biotech innovation in the Middle East and beyond. Passionate about advancing healthcare through technology diplomacy, he is dedicated to democratize the access to life saving treatments.